ATE510544T1 - Kosmetische zusammensetzung enthaltend mindestens ein rhamnosemonomer zur kosmetische behandlung der haut - Google Patents

Kosmetische zusammensetzung enthaltend mindestens ein rhamnosemonomer zur kosmetische behandlung der haut

Info

Publication number
ATE510544T1
ATE510544T1 AT04805348T AT04805348T ATE510544T1 AT E510544 T1 ATE510544 T1 AT E510544T1 AT 04805348 T AT04805348 T AT 04805348T AT 04805348 T AT04805348 T AT 04805348T AT E510544 T1 ATE510544 T1 AT E510544T1
Authority
AT
Austria
Prior art keywords
skin
cosmetic treatment
aging
mucosa
inhibition
Prior art date
Application number
AT04805348T
Other languages
English (en)
Inventor
Jean-Philippe Houlmont
Isabelle Rico-Lattes
Emile Perez
Pascal Bordat
Original Assignee
Fabre Pierre Dermo Cosmetique
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fabre Pierre Dermo Cosmetique, Centre Nat Rech Scient filed Critical Fabre Pierre Dermo Cosmetique
Application granted granted Critical
Publication of ATE510544T1 publication Critical patent/ATE510544T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/02—Monosaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Rheumatology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Toxicology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)
AT04805348T 2003-10-31 2004-10-29 Kosmetische zusammensetzung enthaltend mindestens ein rhamnosemonomer zur kosmetische behandlung der haut ATE510544T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0312798A FR2861729B1 (fr) 2003-10-31 2003-10-31 Monomere d'alkyl-rhamnose ou d'alkyl-fucose, medicament comprenant un monomere d'alkyl-sucre reducteur
PCT/FR2004/002794 WO2005041983A1 (fr) 2003-10-31 2004-10-29 Medicament comprenant un monomere d'alkyl-sucre reducteur pour le traitement des desordres inflammatoires

Publications (1)

Publication Number Publication Date
ATE510544T1 true ATE510544T1 (de) 2011-06-15

Family

ID=34429798

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04805348T ATE510544T1 (de) 2003-10-31 2004-10-29 Kosmetische zusammensetzung enthaltend mindestens ein rhamnosemonomer zur kosmetische behandlung der haut

Country Status (13)

Country Link
US (2) US7666847B2 (de)
EP (2) EP1682158B9 (de)
JP (2) JP5079331B2 (de)
AT (1) ATE510544T1 (de)
BR (1) BRPI0415623B8 (de)
CA (1) CA2544107C (de)
DK (1) DK1682158T3 (de)
ES (1) ES2366908T3 (de)
FR (1) FR2861729B1 (de)
PL (1) PL1682158T3 (de)
PT (1) PT1682158E (de)
SI (1) SI1682158T1 (de)
WO (1) WO2005041983A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2861729B1 (fr) * 2003-10-31 2006-09-08 Fabre Pierre Dermo Cosmetique Monomere d'alkyl-rhamnose ou d'alkyl-fucose, medicament comprenant un monomere d'alkyl-sucre reducteur
ATE540948T1 (de) * 2005-05-20 2012-01-15 Vertex Pharma Pyrrolopyridine als proteinkinasehemmer
WO2007116012A1 (en) * 2006-04-07 2007-10-18 L'oréal Use of a d- and l-fucose-derived c-glycoside compound as an agent for activating and regulating cutaneous immunity
FR2899474B1 (fr) * 2006-04-07 2008-06-06 Oreal Utilisation de compose c-glycoside derive d- et l-fucose comme agent activateur et regulateur de l'imminite cutanee
FR2903003B1 (fr) * 2006-07-03 2012-08-17 Oreal Utilisation d'un derive c-glycoside pour ameliorer la fonction barriere de la peau
FR2902999B1 (fr) 2006-07-03 2012-09-28 Oreal Utilisation de derives c-glycoside a titre d'actif prodesquamant
FR2902998B1 (fr) * 2006-07-03 2012-09-21 Oreal Utilisation d'au moins un derive c-glycoside a titre d'agent apaisant
FR2903004B1 (fr) * 2006-07-03 2009-07-10 Oreal Utilisation en cosmetique d'un derive c-glycoside en association avec de l'acide ascorbique
FR2902996B1 (fr) * 2006-07-03 2008-09-26 Oreal Compositions cosmetiques associant un derive c-glycoside et un derive n-acylaminoamide
FR2903002B1 (fr) * 2006-07-03 2012-08-17 Oreal Composition associant un derive c-glycoside et un polymere emulsionnant
FR2929509B1 (fr) 2008-04-02 2011-01-21 Lvmh Rech L'utilisation de glycosides d'alkyle ou de melanges de glycosides d'alkyle en tant qu'agents destines a inhiber la croissance microbienne, et compositions contenant lesdits glycosides d'alkyle.
FR2929510B1 (fr) 2008-04-02 2011-01-21 Lvmh Rech Utilisation d'au moins un glycoside d'alkyle en tant qu'agen qu'agent anti-vieillissement et/ou calmant des peaux sensibles dans des compositions cosmetiques, et methodes de soin cosmetique utilisant les dites compositions.
FR3074685B1 (fr) * 2017-12-12 2019-11-22 Societe D'exploitation De Produits Pour Les Industries Chimiques Seppic Nouveaux polyol polyrhamnosides, procede pour leur preparation et composition cosmetiques et/ou pharmaceutiques en comprenant
FR3074686B1 (fr) * 2017-12-12 2019-11-15 Societe D'exploitation De Produits Pour Les Industries Chimiques Seppic Nouveaux glyceryl polyrhamnosides, procede pour leur preparation et composition cosmetiques et/ou pharmaceutiques en comprenant

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2652742B1 (fr) * 1989-10-11 1993-10-29 Dominique Vacher Compositions anallergiques cosmetiques et dermo-pharmaceutiques.
JP3662021B2 (ja) * 1993-05-17 2005-06-22 アーヴァント イミュノセラピューティクス インコーポレイテッド 補体関連蛋白質および炭水化物よりなる組成物、ならびに該組成物の製法および使用方法
US5614615A (en) * 1995-03-21 1997-03-25 The Scripps Research Institute Sialyl Lewis X mimetics incorporating fucopeptides
US5728372A (en) 1996-04-29 1998-03-17 L'oreal, S.A. Skin protection, fragrance enhancing and vitamin delivery composition
US5728371A (en) 1996-04-29 1998-03-17 L'oreal, S.A. Skin protection, fragrance enhancing and vitamin delivery composition
FR2756735B1 (fr) * 1996-12-11 1999-02-26 Thorel Jean Noel Agent d'inhibition de l'expression de la proteine d'adherence icam-1 et compositions cosmetiques et pharmaceutiques le contenant
DE19704693A1 (de) * 1997-02-07 1998-08-13 Henkel Kgaa Hautpflegemittel
FR2768623B1 (fr) 1997-09-22 1999-12-31 Jean Noel Thorel Composition cosmetique et/ou dermatologique a usage topique pour le traitement des peaux grasses
US6414037B1 (en) * 1998-01-09 2002-07-02 Pharmascience Pharmaceutical formulations of resveratrol and methods of use thereof
DE19845271A1 (de) * 1998-10-01 2000-04-06 Beiersdorf Ag Verwendung von Alkylglucosiden zur Stabilisierung von Flavonen, Flavanonen bzw. Flavonoiden, synergistische Gemische aus Flavonen, Flavanonen bzw. Flavonoiden und Alkylglucosiden sowie kosmetische und dermatologische Zubereitungen mit einem Gehalt an solchen Gemischen
FR2813789B1 (fr) * 2000-09-11 2003-05-02 Ind E Com De Cosmeticos Natura Nouvelle composition cosmetique ou pharmaceutique comprenant une association de vitamine c et/ou avec un composant fucose, et utilisation de cette association en cosmetique ou pharmacie
EP1318784A1 (de) 2000-09-11 2003-06-18 Industria E Comércio de Cosméticos Natura Ltda. Zusammensetzung mit vitamin c und/oder vitamin a
US6919464B1 (en) * 2001-03-21 2005-07-19 Dow Agrosciences Llc Synthetic derivatives of 21-butenyl and related spinosyns
EP2283864A1 (de) * 2002-07-16 2011-02-16 Elan Pharma International Ltd. Flüssige Zusammensetzung enthaltend stabilisierte Wirkstoff-Nanopartikeln
JP3845368B2 (ja) * 2002-11-18 2006-11-15 株式会社コーセー 液状化粧料
FR2861729B1 (fr) * 2003-10-31 2006-09-08 Fabre Pierre Dermo Cosmetique Monomere d'alkyl-rhamnose ou d'alkyl-fucose, medicament comprenant un monomere d'alkyl-sucre reducteur

Also Published As

Publication number Publication date
JP2012229226A (ja) 2012-11-22
DK1682158T3 (da) 2011-09-12
ES2366908T3 (es) 2011-10-26
WO2005041983A1 (fr) 2005-05-12
JP5642734B2 (ja) 2014-12-17
SI1682158T1 (sl) 2011-10-28
JP5079331B2 (ja) 2012-11-21
EP2266580A1 (de) 2010-12-29
US9163049B2 (en) 2015-10-20
BRPI0415623A (pt) 2006-12-12
CA2544107C (fr) 2013-05-28
CA2544107A1 (fr) 2005-05-12
US20070134187A1 (en) 2007-06-14
US7666847B2 (en) 2010-02-23
BRPI0415623B8 (pt) 2021-05-25
EP2266580B1 (de) 2014-03-26
EP1682158B9 (de) 2012-04-04
FR2861729B1 (fr) 2006-09-08
US20100069311A1 (en) 2010-03-18
JP2007509913A (ja) 2007-04-19
FR2861729A1 (fr) 2005-05-06
PT1682158E (pt) 2011-09-01
EP1682158A1 (de) 2006-07-26
BRPI0415623B1 (pt) 2018-03-13
PL1682158T3 (pl) 2011-10-31
EP1682158B1 (de) 2011-05-25

Similar Documents

Publication Publication Date Title
ATE510544T1 (de) Kosmetische zusammensetzung enthaltend mindestens ein rhamnosemonomer zur kosmetische behandlung der haut
CA2386954C (en) Methods of treating vascular diseases characterized by nitric oxide insufficiency
RU2217125C2 (ru) Косметическая композиция для уменьшения жжения или раздражения кожи, вызванного альфа-гидроксикислотой
HK1048764B (zh) 寡糖醛糖糖酸及其局部應用
DE2711493A1 (de) Substanzen zur behandlung von arthritis
NO172343B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive askorbinsyrederivater
US4677121A (en) Method of inhibiting muscle protein degradation
DE60334485D1 (de) Oxazolidinone für eine pharmazeutische verwendung in hautkrankheiten, autoimmunerkrankungen und transplantatabstossung
FR2802414B1 (fr) Composition, notamment cosmetique ou dermatologique, contenant des oligosaccharides, son procede de preparation et un procede de traitement cosmetique
JPWO2011040495A1 (ja) ヘパラナーゼ活性阻害剤並びにそれを含有するしわ改善剤及び医薬組成物
JP4898089B2 (ja) ランゲルハンス細胞の遊走を阻害するための少なくとも一種のアルカノールアミドを含んでなる組成物およびその使用
JP2004292314A (ja) ケラチノサイト増殖抑制剤
US5217990A (en) Use of macrolactones as anti-allergics
Malo et al. Inhibition by auranofin of pharmacologic and antigen-induced contractions of the isolated guinea pig trachea
WO1998041209A1 (en) Protective agents for cells constituting nervous system
Kang et al. MMP-2, MMP-8 Expression in gingival tissue of Chronic Periodontitis associated to Type 2 Diabetes Mellitus
SU1697734A1 (ru) Способ прогнозировани гнойно-воспалительных осложнений послеоперационных лапаротомных ран
WO2016146843A1 (en) Compositions comprising dihydroquercetin for use in methods for treating herpes
JP2022022672A (ja) 炎症性サイトカイン抑制剤
Cingi et al. Effects of Nicotine on Ureteric Motility
Kaushal et al. Formation and new methods of preparation of 3-acetyl-4-carboxylic heptanol-4-dione-2-6 carboxylic monoethyl ester-1
Melnikov et al. THE USE OF OXYGENATED WATER AND LYMPHATIC THERAPY IN THE TREATMENT OF POST-INJECTION PURULENT COMPLICATIONS IN DRUG ADDICTS
CARROLL EFFECTS OF SEX HORMONES AND OF POTASSIUM SALTS OF FATTY ACIDS ON THE IN VITRO BIOSYNTHESIS OF CHOLESTEROL FROM MEVALONIC ACID-2-CARBON-14
Dejana et al. Salicylate Accumulating During Repeated Aspirin Administration Prevents The Inhibitory Effect Of Aspirin On Vascular Prostacyclin

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1682158

Country of ref document: EP